FTSE 250 movers: Kier slumps; Target Healthcare surges
FTSE 250 (MCX) 19,898.64 0.12%
Infrastructure services firm Kier Group slumped even as it posted a rise in first-half profit and revenue and lifted its dividend as it hailed a record order book.
Domino's Pizza fell despite delivering a 3.8% rise in full-year underlying core earnings as customers tucked into special offers in store and online.
On the upside, a jump in profits at FTSE 100 housebuilder Persimmon helped Vistry and Bellway rack up strong gains.
Elsewhere, Rotork also rose on the back of results.
Target Healthcare REIT surged on news that Care REIT agreed to be bought by US care home provider CareTrust REIT in a £448m deal.
Market Movers
FTSE 250 - Risers
Target Healthcare Reit Ltd (THRL) 92.90p 7.03%
Rotork (ROR) 328.00p 4.93%
Bellway (BWY) 2,310.00p 4.05%
Vistry Group (VTY) 625.00p 3.48%
IP Group (IPO) 40.10p 3.22%
Greggs (GRG) 1,912.00p 3.18%
Endeavour Mining (EDV) 1,668.00p 3.09%
Oxford Nanopore Technologies (ONT) 97.40p 2.96%
Discoverie Group (DSCV) 546.00p 2.82%
Primary Health Properties (PHP) 96.55p 2.82%
FTSE 250 - Fallers
Kier Group (KIE) 121.40p -13.29%
TBC Bank Group (TBCG) 4,125.00p -3.40%
Domino's Pizza Group (DOM) 284.20p -3.00%
Just Group (JUST) 137.40p -2.41%
Me Group International (MEGP) 187.00p -2.40%
Dr. Martens (DOCS) 55.25p -2.30%
Carnival (CCL) 1,351.50p -2.07%
Ocado Group (OCDO) 243.50p -2.01%
Lancashire Holdings Limited (LRE) 588.00p -2.00%
Drax Group (DRX) 559.50p -1.93%
Disclaimer & Declaration of Interest
The information, investment views and recommendations in this article are provided for general information purposes only. Nothing in this article should be construed as a solicitation to buy or sell any financial product relating to any companies under discussion or to engage in or refrain from doing so or engaging in any other transaction. Any opinions or comments are made to the best of the knowledge and belief of the writer but no responsibility is accepted for actions based on such opinions or comments. Vox Markets may receive payment from companies mentioned for enhanced profiling or publication presence. The writer may or may not hold investments in the companies under discussion.